Literature DB >> 8655728

Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.

G F Webster1, R L Knobler, F D Lublin, E M Kramer, L R Hochman.   

Abstract

Seven patients with multiple sclerosis who were receiving subcutaneous injections of recombinant interferon beta had pain followed by ulceration at the injection site. An eighth patient had a pustular flare of her usually mild psoriasis. No evidence of infection or contaminated medication was found.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655728     DOI: 10.1016/s0190-9622(07)80010-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

Review 1.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis.

Authors:  Barry G W Arnason
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

Review 3.  Managing the adverse effects of interferon-beta therapy in multiple sclerosis.

Authors:  A Bayas; P Rieckmann
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 4.  Interferon-β exacerbates Th17-mediated inflammatory disease.

Authors:  Robert C Axtell; Chander Raman; Lawrence Steinman
Journal:  Trends Immunol       Date:  2011-04-29       Impact factor: 16.687

Review 5.  Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity.

Authors:  Robert C Axtell; Chander Raman; Lawrence Steinman
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 6.  Antimicrobial peptides in the pathogenesis of psoriasis.

Authors:  Shin Morizane; Richard L Gallo
Journal:  J Dermatol       Date:  2012-03       Impact factor: 4.005

7.  Psoriasis during natalizumab treatment for multiple sclerosis.

Authors:  Jorge Millán-Pascual; Laura Turpín-Fenoll; Pablo Del Saz-Saucedo; Ignacio Rueda-Medina; Santiago Navarro-Muñoz
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

8.  Psoriasis during interferon beta treatment for multiple sclerosis.

Authors:  Loredana La Mantia; F Capsoni
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307

9.  Embolia cutis medicamentosa (nicolau syndrome) : two cases due to different drugs in distinct age groups.

Authors:  Atilla Ozcan; Mustafa Senol; Engin N Aydin; Tuba Aki
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

10.  Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?

Authors:  Heiko Mühl
Journal:  Front Immunol       Date:  2013-02-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.